Haemonetics Corp Mass (HAE) Hedge Fund Ownership (Q2 2026)

Haemonetics Corp Mass (HAE)

325 + Investors. Track Smart Money conviction in HAE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — HAE

Based on 330 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added HAE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

330 hedge funds hold HAE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +10% more funds vs a year ago

fund count last 6Q

+30 new funds entered over the past year (+10% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟠

More sellers than buyers — 49% buying

166 buying173 selling

Last quarter: 173 funds reduced or exited vs 166 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

📈

More new buyers each quarter (+6 vs last Q)

new funds entering per quarter

Funds opening a new HAE position: 57 → 79 → 53 → 59. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

63% of holders stayed for 2+ years

■ 63% conviction (2yr+) ■ 17% medium ■ 19% new

209 out of 330 hedge funds have held HAE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💰

Value +40% but shares only +13% — price-driven

Value

+39%

+13%

Last quarter: the total dollar value of institutional holdings rose +40%, but actual share count only changed +13%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

📊

Peak discovery — momentum slowing

35 → 57 → 79 → 53 → 59 new funds/Q

New funds entering each quarter: 57 → 79 → 53 → 59. HAE is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

🏛️

Veteran-anchored — 67% veterans vs 22% newcomers

■ 67% veterans ■ 11% 1-2yr ■ 22% new

Entry-cohort mix of 339 holders: 227 (67%) are 2+ year veterans, 38 entered 1–2 years ago, and 74 (22%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

🏆

Elite ownership — 61% AUM from top-100 funds

61% from top-100 AUM funds

52 of 328 holders are among the 100 largest funds by AUM, controlling 61% of total institutional value in HAE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

3.6

out of 10

Low Exit Risk

Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	325	321	1.25%
13F Shares	50M	48M	4.96%
Total Value	$3.59B	$2.61B	37.61%
New Positions	58	53	+5
Increased Positions	104	116	-12
Closed Positions	52	61	-9
Reduced Positions	120	113	+7
Total Calls	6	3	100.0%
Total Puts	5	5	-
PUT/CALL Ratio	0.83	1.67	Neutral

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

325

321

1.25%

13F Shares

50M

48M

4.96%

Total Value

$3.59B

$2.61B

37.61%

New Positions

Increased Positions

104

116

-12

Closed Positions

-9

Reduced Positions

120

113

Total Calls

100.0%

Total Puts

PUT/CALL Ratio

0.83

1.67

Neutral

Institutional Holders (2026 Q2)

325 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HAE. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 HAE holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Kestrel Investment Management Corp	3.98%	97,400	$7.3M
2	North Peak Capital Management, LLC	2.86%	343,077	$25.7M
3	Expect Equity LLC	1.98%	41,026	$3.1M
4	Ariel Investments, LLC	1.54%	2,060,966	$154.6M
5	Aristotle Capital Boston, LLC	1.46%	289,624	$21.7M
6	Dean Capital Management	1.22%	44,968	$3.4M
7	River Road Asset Management, LLC	1.07%	1,285,602	$96.4M
8	Riverwater Partners LLC	1.06%	47,645	$3.6M
9	Aurora Investment Counsel	0.98%	25,501	$1.9M
10	Nierenberg Investment Management Company, LLC	0.98%	26,280	$2.0M
11	Invenomic Capital Management LP	0.97%	216,217	$16.2M
12	Beacon Investment Advisors LLC	0.87%	37,115	$2.8M
13	Heartland Advisors Inc	0.67%	200,000	$15.0M
14	Dean Investment Associates, LLC	0.61%	61,989	$4.6M
15	Isthmus Partners, LLC	0.48%	65,951	$4.9M
16	Phocas Financial Corp.	0.45%	43,030	$3.2M
17	Skylands Capital, LLC	0.44%	47,625	$3.6M
18	May Hill Capital, LLC	0.35%	22,388	$1.7M
19	Boston Trust Walden Corp	0.33%	585,148	$43.9M
20	Mizuho Markets Americas LLC	0.33%	282,214	$21.2M
21	Fort Washington Investment Advisors Inc /Oh/	0.31%	830,925	$62.3M
22	Connors Investor Services Inc	0.27%	42,000	$3.1M
23	Longaeva Partners L.P.	0.27%	163,822	$12.3M
24	Silvercrest Asset Management Group LLC	0.24%	493,796	$37.0M
25	Cardinal Capital Management	0.23%	24,817	$1.9M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Haemonetics Corp Mass (HAE)

What does the Smart Money Trend signal show for HAE?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added HAE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for HAE?

More sellers than buyers — 49% buying: Last quarter: 173 funds reduced or exited vs 166 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for HAE holders?

Elite ownership — 61% AUM from top-100 funds: 52 of 328 holders are among the 100 largest funds by AUM, controlling 61% of total institutional value in HAE. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held HAE?

63% of holders stayed for 2+ years: 209 out of 330 hedge funds have held HAE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Haemonetics Corp Mass (HAE)

Smart Money Signals — HAE

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Steady growth — +10% more funds vs a year ago

More sellers than buyers — 49% buying

More new buyers each quarter (+6 vs last Q)

63% of holders stayed for 2+ years

Value +40% but shares only +13% — price-driven

Peak discovery — momentum slowing

Veteran-anchored — 67% veterans vs 22% newcomers

Elite ownership — 61% AUM from top-100 funds

Institutional Sentiment Summary — HAE

Hedge Fund Ownership: HAE

Market Analysis: HAE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: HAE

Hedge Fund Positioning: HAE

Statistics: HAE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Haemonetics Corp Mass (HAE)

Welcome to 13Foresight!